Patents by Inventor Junyu KIM

Junyu KIM has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL COMPOSITION COMPRISING 1-(3-CYANO-1-ISOPROPYL-INDOL-5-YL)PYRAZOLE-4-CARBOXYLIC ACID
    Publication number: 20240415814
    Abstract: The present invention relates to a pharmaceutical composition comprising 1-(3-cyano-1-isopropyl-indol-5-yl)pyrazol-4-carboxylic acid or a pharmaceutically acceptable salt thereof, and a method of treating or inhibiting a hyperuricemia-related disease using the same, and the pharmaceutical composition of the present invention may effectively reduce the serum uric acid concentration in a patient with a hyperuricemia-related disease.
    Type: Application
    Filed: August 28, 2024
    Publication date: December 19, 2024
    Inventors: Jieun LEE, Heemin GWAK, Seong Hye SHIN, Ji Young MIN, Min Hee KIM, Junyu KIM, Jung Youn SEO, June Sik MUNE
  • PHARMACEUTICAL COMPOSITION COMPRISING 1-(3-CYANO-1-ISOPROPYL-INDOL-5-YL)PYRAZOLE-4-CARBOXYLIC ACID
    Publication number: 20240293369
    Abstract: The present invention relates to a pharmaceutical composition comprising 1-(3-cyano-1-isopropyl-indol-5-yl)pyrazol-4-carboxylic acid or a pharmaceutically acceptable salt thereof, and a method of treating or inhibiting a hyperuricemia-related disease using the same, and the pharmaceutical composition of the present invention may effectively reduce the blood uric acid concentration in a patient with a hyperuricemia-related disease.
    Type: Application
    Filed: June 15, 2022
    Publication date: September 5, 2024
    Inventors: Jieun LEE, Heemin GWAK, Seong Hye SHIN, Ji Young MIN, Min Hee KIM, Junyu KIM, Jung Youn SEO, June Sik MUNE
  • PHARMACEUTICAL COMPOSITION COMPRISING 1-(3-CYANO-1-ISOPROPYL-INDOL-5-YL)PYRAZOLE-4-CARBOXYLIC ACID
    Publication number: 20240285583
    Abstract: The present invention relates to a pharmaceutical composition comprising 1-(3-cyano-1-isopropyl-indol-5-yl)pyrazol-4-carboxylic acid or a pharmaceutically acceptable salt thereof, and a method of treating or inhibiting a hyperuricemia-related disease using the same, and the pharmaceutical composition of the present invention may effectively reduce the blood uric acid concentration in a patient with a hyperuricemia-related disease.
    Type: Application
    Filed: June 15, 2022
    Publication date: August 29, 2024
    Inventors: Jieun LEE, Heemin GWAK, Seong Hye SHIN, Ji Young MIN, Min Hee KIM, Junyu KIM, Jung Youn SEO, June Sik MUNE